Objective: Report for first time in Mexico a case of hereditary mixed polyposis and review the literature.

Background: The hereditary mixed polyposis syndrome (HMPS) is an uncommon condition, distinguished by presence of a different histological pattern of polyps in digestive tract, clinically manifested by diarrhea, anemia and weight loss.

Case Report: Male patient, 38 years old, with familiar antecedent (dead sister) with polyps and gastric cancer. With history of a 1 year with bleeding and mucous diarrhea, and weight loss of a 28.6 pounds. Pale at physical examination, without abdominal signs. At blood test with hemoglobin of 9.7 g/dL, and colonoscopy with multiple polyps within colon and rectum, upper endoscopy with a big esophageal polyp and multiple polyps in gastric and duodenal lining smaller than 1 cm. Contrast study of intestine was normal. Histopathologic study of the polyps report mixed pattern of polyps: (hyperplasic-adenomatous, juvenile-adenomatous, adenoma-inflammatory-hyperplasic, hyperplasic-adenomatous with a high degree dysplasia); juvenile in esophagus, and hyperplasic in stomach and duodenum. Patient was undergone to totalproctocolectomy and reconstruction by "J" ileoanal pouch with good outcome, and endoscopic esophageal polypectomy, with actual surveillance.

Download full-text PDF

Source

Publication Analysis

Top Keywords

mixed polyposis
12
polyposis syndrome
8
hereditary mixed
8
pattern polyps
8
polyps gastric
8
multiple polyps
8
polyps
6
[hereditary mixed
4
report
4
syndrome report
4

Similar Publications

Familial adenomatous polyposis (FAP) is a rare inherited disorder characterized by numerous adenomatous polyps throughout the colon and rectum, leading to a significantly increased risk of colorectal cancer. We present the case of a 19-year-old male patient with a known family history of FAP who presented with recurrent lower abdominal pain, altered bowel habits, and rectal bleeding. Initial examination identified rectal polyps, and subsequent colonoscopy revealed multiple adenomatous polyps.

View Article and Find Full Text PDF

Biologics in Chronic Rhinosinusitis: Current and Emerging.

Immunol Allergy Clin North Am

November 2024

Department of Otolaryngology - Head and Neck Surgery, University of Colorado Anschutz School of Medicine, 12631 East 17th Avenue, MSB 205 Room 3001, Aurora, CO 80045, USA. Electronic address:

Article Synopsis
  • Chronic rhinosinusitis (CRS) is divided into two main types: with nasal polyps (CRSwNP) and without nasal polyps (CRSsNP), and can also be classified by immune response into Type 1, Type 2, and Type 3.
  • The Type 2 endotype is heavily researched, often linked to conditions like asthma and severe cases of CRSwNP.
  • For patients struggling with severe CRSwNP, there are three FDA-approved biologic treatments—omalizumab, dupilumab, and mepolizumab— with ongoing research into additional biologics for various endotypes to improve CRS treatment options.
View Article and Find Full Text PDF

Histopathologic evaluation of Asian-American patients with chronic rhinosinusitis with nasal polyps.

Int Forum Allergy Rhinol

November 2024

Division of Otolaryngology-Head & Neck Surgery, Cedars-Sinai Medical Center, Los Angeles, California, USA.

Asian-American (AA) patients with chronic rhinosinusitis with nasal polyps (CRSwNP) have comparable rates of tissue eosinophilia compared to Caucasians when defined as >10 eosinophils/high-powered field (HPF). AA patients with CRSwNP have significantly higher incidence of mixed inflammation defined as >10 eosinophils/HPF and >10 neutrophils/HPF.

View Article and Find Full Text PDF

Mixed adenoma-neuroendocrine tumor of the stomach: analysis of nine cases with literature review.

Virchows Arch

June 2024

Department of Pathology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-Ku, Tokyo, 113-0033, Japan.

Mixed adenoma-neuroendocrine tumor (MANET) comprises adenoma and well-differentiated neuroendocrine tumor (NET) components. Given the limited information on this due to its rarity, we aimed to clarify the clinicopathologic features and optimal management of gastric MANETs in a case series and literature review. Nine patients with gastric MANETs, including eight male and one female patient (mean age, 72 years), were identified from the institutional pathology archive.

View Article and Find Full Text PDF
Article Synopsis
  • DNA methylation is an epigenetic modification that silences gene expression and is frequently observed in bladder cancer, particularly affecting patients with neurogenic lower urinary tract dysfunction (NLUTD), where it contributes to tumor development and severity.
  • The study analyzed the methylation profiles of five specific gene promoters in bladder tissue samples from NLUTD patients and found DNA hypermethylation in all samples, with RARβ being the most affected.
  • A significant correlation was observed between the number of hypermethylated genes and recurrent urinary tract infections (UTIs), although no other clinical characteristics showed significant associations with DNA hypermethylation.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!